International Development Grant
Support to the Maternal and Neonatal Tetanus Elimination
Project Number: CA-3-D001694001
Status: Closed
Country/Region:
Maximum Contribution: $2,500,000.00
Start Date: May 22, 2015
End Date: December 28, 2019
Duration: 4.6 years
Project Description
The project aims to reduce the incidence of child and maternal mortality in targeted countries through maternal and neonatal tetanus elimination (MNTE). Maternal and neonatal tetanus (MNT) is a deadly disease that affects women and children in developing countries. When women give birth in unhygienic circumstances both mother and baby are at risk of contracting tetanus if they are not protected by vaccination. With Canada's support UNICEF Canada is providing tetanus vaccine to at least 3 401 448 women of reproductive age and their future newborns in Pakistan Sudan Chad Kenya and South Sudan. Project activities include: (1) distributing vaccines and supplies for supplemental immunization activities; (2) strengthening of the cold chain to transport vaccines and supplies; (3) promoting clean delivery practices routine immunization and antenatal care; (4) developing and implementing national plans of action training and support for health workers; and (5) strengthening surveillance of MNTE to monitor and evaluate progress.
Expected Results
The expected results for this project include: (1) increased number of countries have progressed towards and validated MNT elimination; and (2) increased understanding by Canadians of MNCH the value of MNTE to save children’s lives and Canada’s leadership role on these issues.
Key Information
Executing Agency:
UNICEF CANADA
Reporting Organization:
Global Affairs Canada
Program:
YFMInternaAssistPartnershp&Programing Br
Last Modified:
September 19, 2025
Development Classifications
DAC Sector:
Aid Type: Contributions to specific-purpose programmes and funds managed by implementing partners
Collaboration: Bilateral
Finance Type: Aid grant excluding debt reorganisation
Selection Mechanism:
Department-Initiated